Odisha News In English

Prameya English, Prameyanews.com, Odisha Latest News, Odisha News Online

Covaxin use for children aged between 2-18 years awaited to get DCGI approval

12/10/2021 at 4:41 PM

New Delhi, Oct 12: Covaxin is yet to get approval by the Drugs Controller General of India (DCGI) for children between 2-18 years old, according to official sources.

The Bharat Biotech has submitted data from clinical trials in the 2-18 years age group for COVAXIN (BBV152) to Central Drugs Standard Control Organisation (CDSCO). The data has been thoroughly reviewed by the CDSCO and Subject Experts Committee (SEC) who have provided their positive recommendations.

   Related Posts